Hoffmann, J., Knoop, C., Schäkel, K., Enk, A., & Hadaschik, E. (2021). Evaluation of psoriasis area and severity index as a proxy for biomarkers of systemic disease under treatment with tumour necrosis factor-alpha and interleukin 12/23 antagonists in patients with psoriasis: A retrospective cohort study of 186 treatment cycles. Acta dermato-venereologica, 101, . https://doi.org/10.2340/00015555-3814
Chicago-Zitierstil (17. Ausg.)Hoffmann, Jochen, Christian Knoop, Knut Schäkel, Alexander Enk, und Eva Hadaschik. "Evaluation of Psoriasis Area and Severity Index as a Proxy for Biomarkers of Systemic Disease Under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles." Acta Dermato-venereologica 101 (2021). https://doi.org/10.2340/00015555-3814.
MLA-Zitierstil (9. Ausg.)Hoffmann, Jochen, et al. "Evaluation of Psoriasis Area and Severity Index as a Proxy for Biomarkers of Systemic Disease Under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles." Acta Dermato-venereologica, vol. 101, 2021, https://doi.org/10.2340/00015555-3814.